Microfluidic Manipulation of Core/Shell Nanoparticles for Oral Delivery of Chemotherapeutics: A New Treatment Approach for Colorectal Cancer

A microfluidics approach to synthesize core-shell nanocarriers with high pH tunability is described. The sacrificial shell protects the core layer with the drugs and prevents their release in the severe pH conditions of the gastrointestinal tract, while allowing for drug release in the proximity of a tumor. The proposed nanoparticulate drug-delivery system is designed for the oral administration of cancer therapeutics.

[1]  P. Renaud,et al.  Morphological tuning of polymeric nanoparticles via microfluidic platform for fuel cell applications. , 2012, Journal of the American Chemical Society.

[2]  Mayur M. Patel,et al.  Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer , 2011, Drug delivery.

[3]  P. Johnston,et al.  Implementing prognostic and predictive biomarkers in CRC clinical trials , 2011, Nature Reviews Clinical Oncology.

[4]  Kirsten Sandvig,et al.  Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies , 2011 .

[5]  M. Saunders,et al.  Cytotoxicity of monodispersed chitosan nanoparticles against the Caco-2 cells. , 2012, Toxicology and applied pharmacology.

[6]  Y. Okahata,et al.  In vitro gene delivery mediated by chitosan. effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. , 2001, Biomaterials.

[7]  Renuka Khatik,et al.  Toxicological evaluation and targeting tumor cells through folic acid modified guar gum nanoparticles of curcumin. , 2014 .

[8]  N. Bedford,et al.  Engineered multifunctional nanocarriers for cancer diagnosis and therapeutics. , 2011, Small.

[9]  Joonyoung Park,et al.  Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery. , 2012, Molecular pharmaceutics.

[10]  Kinam Park,et al.  A new hydrotropic block copolymer micelle system for aqueous solubilization of paclitaxel. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[11]  D F Evans,et al.  Gastrointestinal intraluminal pH in normal subjects and those with colorectal adenoma or carcinoma. , 1990, Gut.

[12]  Rahul P Gangwal,et al.  Oral delivery of anticancer drugs: challenges and opportunities. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Wei Zhang,et al.  Paclitaxel-loaded micelles composed of folate-poly(ethylene glycol) and poly(γ-benzyl l-glutamate) diblock copolymer , 2010 .

[14]  Hua Yue,et al.  Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. , 2011, Biomacromolecules.

[15]  B. Sarmento,et al.  Chitosan-based systems for biopharmaceuticals : delivery, targeting, and polymer therapeutics , 2012 .

[16]  Si-Shen Feng,et al.  Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. , 2005, Biomaterials.

[17]  L. Liu,et al.  DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts. , 1989, Science.

[18]  N. Bird,et al.  Current diagnostic and therapeutic approaches for colorectal cancer liver metastasis. , 2008, Hippokratia.

[19]  J. Fallingborg,et al.  Intraluminal pH of the human gastrointestinal tract. , 1999, Danish medical bulletin.

[20]  A. Krešo,et al.  Self-renewal as a therapeutic target in human colorectal cancer , 2013, Nature Medicine.

[21]  Ming-Jium Shieh,et al.  Development of thermosensitive poly(n-isopropylacrylamide-co-((2-dimethylamino) ethyl methacrylate))-based nanoparticles for controlled drug release , 2011, Nanotechnology.

[22]  Jianzhong Du,et al.  Ultrasound and pH Dually Responsive Polymer Vesicles for Anticancer Drug Delivery , 2013, Scientific Reports.

[23]  Mohammad Mahdi Hasani-Sadrabadi,et al.  On‐Chip Fabrication of Paclitaxel‐Loaded Chitosan Nanoparticles for Cancer Therapeutics , 2014 .

[24]  L. Kong,et al.  Microencapsulation of nanoparticles with enhanced drug loading for pH‐sensitive oral drug delivery for the treatment of colon cancer , 2013 .

[25]  Erfan Dashtimoghadam,et al.  Microfluidic‐Assisted Self‐Assembly of Complex Dendritic Polyethylene Drug Delivery Nanocapsules , 2014, Advanced materials.

[26]  G. Whitesides.  The origins and the future of microfluidics , 2006, Nature.

[27]  Yu-qiang Ma,et al.  Controlling Cellular Uptake of Nanoparticles with pH-Sensitive Polymers , 2013, Scientific Reports.

[28]  Omid C Farokhzad,et al.  pH-Responsive nanoparticles for drug delivery. , 2010, Molecular pharmaceutics.

[29]  J. Mano,et al.  Drug release of pH/temperature-responsive calcium alginate/poly(N-isopropylacrylamide) semi-IPN beads. , 2006, Macromolecular bioscience.

[30]  G. Lu,et al.  A pH-responsive drug delivery system based on chitosan coated mesoporous silica nanoparticles , 2012 .

[31]  M. Loeffler,et al.  Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. , 2006, The Journal of clinical investigation.

[32]  H. Jerrard,et al.  Measurement of Relaxation Times of Macromolecules by the Kerr Effect , 1962, Nature.

[33]  Varun Jain,et al.  Design and in vitro evaluation of formulations with pH and transit time controlled sigmoidal release profile for colon-specific delivery , 2009, Drug delivery.

[34]  N. Peppas,et al.  pH-Responsive hydrogels containing PMMA nanoparticles: an analysis of controlled release of a chemotherapeutic conjugate and transport properties , 2013, Journal of biomaterials science. Polymer edition.

[35]  Mohammad Mahdi Hasani-Sadrabadi,et al.  Microfluidic assisted self-assembly of chitosan based nanoparticles as drug delivery agents. , 2013, Lab on a chip.

[36]  V. Muzykantov,et al.  Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities , 2012, Science.

[37]  Erfan Dashtimoghadam,et al.  Microfluidic self-assembly of polymeric nanoparticles with tunable compactness for controlled drug delivery , 2013 .

[38]  M. Ferrari.  Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.

[39]  Vladimir P Torchilin,et al.  Passive and active drug targeting: drug delivery to tumors as an example. , 2010, Handbook of experimental pharmacology.

[40]  M. Janmaleki,et al.  Chitosan microparticles loaded with exotoxin A subunit antigen for intranasal vaccination against Pseudomonas aeruginosa: An in vitro study , 2011 .

[41]  D. K. Mohapatra,et al.  Synthesis and colon-specific drug delivery of a poly(acrylic acid-co-acrylamide)/MBA nanosized hydrogel , 2008, Journal of biomaterials science. Polymer edition.

[42]  Patrice D Cani,et al.  Targeted nanoparticles with novel non-peptidic ligands for oral delivery. , 2013, Advanced drug delivery reviews.

[43]  T. Yang,et al.  Antitumor Effect of Paclitaxel-Loaded PEGylated Immunoliposomes Against Human Breast Cancer Cells , 2007, Pharmaceutical Research.

[44]  C. Lipschultz,et al.  Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines. , 1993, British Journal of Cancer.